Welcome to Brunel Laboratoria

Brunel is a privately owned pharmaceutical
company with a strong footprint in South Africa.

WHO WE ARE

A PRIVATELY OWNED PHARMACEUTICAL COMPANY

Brunel delivers trusted healthcare solutions backed by five decades of pharmaceutical expertise and innovative, end-to-end distribution.

Established in 1974, Brunel has spent decades building successful partnerships - working with businesses to produce, distribute, and manage a wide range of healthcare brands and products. Our diverse portfolio includes oral health solutions, haircare and eye care products, vitamins and minerals, sun protection, lubricant gels, disinfectants, probiotics, and more.

MORE ABOUT BRUNEL

OUR MISSION

To provide reliable, compliant and efficient distribution of pharmaceutical and healthcare products through strategic partnerships, operational excellence, and a commitment to quality across every stage of the supply chain

THE BRUNEL ADVANTAGE

WHY PARTNER WITH BRUNEL?

01

50 years experience

Over 50 years of proven experience in the South African pharmaceutical industry

02

Direct delivery

Direct delivery from manufacturer, supported by efficient wholesale and third-party channels

03

Extensive portfolio

Extensive portfolio of pharmaceuticals, complementary medicines, and personal care products

04

Custom-built facility

Fully temperature- and access-controlled, enabling direct delivery from manufacturer to client.

05

Reliable partner

A reliable partner with a strong track record in managing and distributing leading healthcare brands.

Empty
Click + to add content
LATEST NEWS

LIVE WELL WITH BRUNEL

What causes hay fever?

What causes hay fever?
Publish date: 01 Sep 2025

Discover the causes of hay fever in South Africa, from pollen to pollution, and learn why symptoms can feel worse compared to other regions.

READ MORE

How to stay healthy in spring

How to stay healthy in spring
Publish date: 13 Aug 2025

Practical tips to refresh your health this spring - from eating seasonal foods to boosting activity, protecting your skin, keeping hydrated to rest, and mental...

READ MORE

Brunel acquires MYOPRIN 100 mg

Brunel acquires MYOPRIN 100 mg
Publish date: 01 Jul 2025

Brunel Laboratoria expands its portfolio with the acquisition of MYOPRIN 100 mg Tablets, strengthening its cardiovascular medicines offering.

READ MORE

2,200

ACTIVE CUSTOMER ACCOUNTS

With over 1,700 clients serviced every month.

1,800 m2

CUSTOM-BUILT DISTRIBUTION CENTRE

fully temperature- and access-controlled

100+

PRODUCTS AND BRANDS

Managed and owned products and brands.

Experience you can trust, delivery you can count on.

CONTACT BRUNEL TODAY